お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、抗凝固剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に抗凝固剤市場を分類しています。
本レポートでは世界の抗凝固剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Sanofi、Bayer、Boehringer Ingelheim、Johnson & Johnson、Genentech (Roche)、AstraZeneca、Bristol-Myers Squibb、Aspen、Lilly、Otsuka、Pfizer、Daiichi Sankyo、The Medicines Company

レポートは抗凝固剤の主要生産者を調査し、主要地域や国の消費状況も提供します。抗凝固剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Platelet Aggregation Inhibitors (PAI)
    Low-Molecular-Weight Heparin (LMWH)
    Direct Thrombin Inhibitor (DTI)
    Direct Factor Xa Inhibitors (DFXa)
    Vitamin K Antagonists (VKA)
    Others

用途別の市場セグメント：
    VTE
    ACS/MI
    AF
    Others

本レポートの詳細内容
本レポートは、世界の抗凝固剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて抗凝固剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の抗凝固剤生産量、成長率、市場シェアを調査している。

二. 消費面では、抗凝固剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの抗凝固剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の抗凝固剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本抗凝固剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：抗凝固剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 抗凝固剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける抗凝固剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章抗凝固剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：抗凝固剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：抗凝固剤の主要メーカーの概要を提供し、製品の説明と仕様、抗凝固剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：抗凝固剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Decoagulant market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Decoagulant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Decoagulant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Decoagulant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Decoagulant include Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), AstraZeneca, Bristol-Myers Squibb, Aspen and Lilly, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Decoagulant, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Decoagulant, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Decoagulant, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Decoagulant sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Decoagulant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Decoagulant sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), AstraZeneca, Bristol-Myers Squibb, Aspen and Lilly, etc.

Market Segmentation
By Company
    Sanofi
    Bayer
    Boehringer Ingelheim
    Johnson & Johnson
    Genentech (Roche)
    AstraZeneca
    Bristol-Myers Squibb
    Aspen
    Lilly
    Otsuka
    Pfizer
    Daiichi Sankyo
    The Medicines Company

Segment by Type
    Platelet Aggregation Inhibitors (PAI)
    Low-Molecular-Weight Heparin (LMWH)
    Direct Thrombin Inhibitor (DTI)
    Direct Factor Xa Inhibitors (DFXa)
    Vitamin K Antagonists (VKA)
    Others

Segment by Application
    VTE
    ACS/MI
    AF
    Others

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Decoagulant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Decoagulant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Decoagulant sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Decoagulant Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Platelet Aggregation Inhibitors (PAI)
    Table 3. Major Manufacturers of Low-Molecular-Weight Heparin (LMWH)
    Table 4. Major Manufacturers of Direct Thrombin Inhibitor (DTI)
    Table 5. Major Manufacturers of Direct Factor Xa Inhibitors (DFXa)
    Table 6. Major Manufacturers of Vitamin K Antagonists (VKA)
    Table 7. Major Manufacturers of Others
    Table 8. Global Decoagulant Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Decoagulant Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Decoagulant Revenue by Region (2019-2024) & (US$ Million)
    Table 11. Global Decoagulant Revenue by Region (2025-2030) & (US$ Million)
    Table 12. Global Decoagulant Revenue Market Share by Region (2019-2024)
    Table 13. Global Decoagulant Revenue Market Share by Region (2025-2030)
    Table 14. Global Decoagulant Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 15. Global Decoagulant Sales by Region (2019-2024) & (K Doses)
    Table 16. Global Decoagulant Sales by Region (2025-2030) & (K Doses)
    Table 17. Global Decoagulant Sales Market Share by Region (2019-2024)
    Table 18. Global Decoagulant Sales Market Share by Region (2025-2030)
    Table 19. Global Decoagulant Sales by Manufacturers (2019-2024) & (K Doses)
    Table 20. Global Decoagulant Sales Share by Manufacturers (2019-2024)
    Table 21. Global Decoagulant Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 22. Global Decoagulant Revenue Share by Manufacturers (2019-2024)
    Table 23. Global Key Players of Decoagulant, Industry Ranking, 2022 VS 2023 VS 2024
    Table 24. Decoagulant Price by Manufacturers 2019-2024 (USD/Dose)
    Table 25. Global Decoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 26. Global Decoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decoagulant as of 2023)
    Table 27. Global Key Manufacturers of Decoagulant, Manufacturing Base Distribution and Headquarters
    Table 28. Global Key Manufacturers of Decoagulant, Product Offered and Application
    Table 29. Global Key Manufacturers of Decoagulant, Date of Enter into This Industry
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Decoagulant Sales by Type (2019-2024) & (K Doses)
    Table 32. Global Decoagulant Sales by Type (2025-2030) & (K Doses)
    Table 33. Global Decoagulant Sales Share by Type (2019-2024)
    Table 34. Global Decoagulant Sales Share by Type (2025-2030)
    Table 35. Global Decoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 36. Global Decoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 37. Global Decoagulant Revenue Share by Type (2019-2024)
    Table 38. Global Decoagulant Revenue Share by Type (2025-2030)
    Table 39. Decoagulant Price by Type (2019-2024) & (USD/Dose)
    Table 40. Global Decoagulant Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 41. Global Decoagulant Sales by Application (2019-2024) & (K Doses)
    Table 42. Global Decoagulant Sales by Application (2025-2030) & (K Doses)
    Table 43. Global Decoagulant Sales Share by Application (2019-2024)
    Table 44. Global Decoagulant Sales Share by Application (2025-2030)
    Table 45. Global Decoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 46. Global Decoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 47. Global Decoagulant Revenue Share by Application (2019-2024)
    Table 48. Global Decoagulant Revenue Share by Application (2025-2030)
    Table 49. Decoagulant Price by Application (2019-2024) & (USD/Dose)
    Table 50. Global Decoagulant Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 51. US & Canada Decoagulant Sales by Type (2019-2024) & (K Doses)
    Table 52. US & Canada Decoagulant Sales by Type (2025-2030) & (K Doses)
    Table 53. US & Canada Decoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 54. US & Canada Decoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 55. US & Canada Decoagulant Sales by Application (2019-2024) & (K Doses)
    Table 56. US & Canada Decoagulant Sales by Application (2025-2030) & (K Doses)
    Table 57. US & Canada Decoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 58. US & Canada Decoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 59. US & Canada Decoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 60. US & Canada Decoagulant Revenue by Country (2019-2024) & (US$ Million)
    Table 61. US & Canada Decoagulant Revenue by Country (2025-2030) & (US$ Million)
    Table 62. US & Canada Decoagulant Sales by Country (2019-2024) & (K Doses)
    Table 63. US & Canada Decoagulant Sales by Country (2025-2030) & (K Doses)
    Table 64. Europe Decoagulant Sales by Type (2019-2024) & (K Doses)
    Table 65. Europe Decoagulant Sales by Type (2025-2030) & (K Doses)
    Table 66. Europe Decoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 67. Europe Decoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 68. Europe Decoagulant Sales by Application (2019-2024) & (K Doses)
    Table 69. Europe Decoagulant Sales by Application (2025-2030) & (K Doses)
    Table 70. Europe Decoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 71. Europe Decoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 72. Europe Decoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 73. Europe Decoagulant Revenue by Country (2019-2024) & (US$ Million)
    Table 74. Europe Decoagulant Revenue by Country (2025-2030) & (US$ Million)
    Table 75. Europe Decoagulant Sales by Country (2019-2024) & (K Doses)
    Table 76. Europe Decoagulant Sales by Country (2025-2030) & (K Doses)
    Table 77. China Decoagulant Sales by Type (2019-2024) & (K Doses)
    Table 78. China Decoagulant Sales by Type (2025-2030) & (K Doses)
    Table 79. China Decoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 80. China Decoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 81. China Decoagulant Sales by Application (2019-2024) & (K Doses)
    Table 82. China Decoagulant Sales by Application (2025-2030) & (K Doses)
    Table 83. China Decoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 84. China Decoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 85. Asia Decoagulant Sales by Type (2019-2024) & (K Doses)
    Table 86. Asia Decoagulant Sales by Type (2025-2030) & (K Doses)
    Table 87. Asia Decoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 88. Asia Decoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 89. Asia Decoagulant Sales by Application (2019-2024) & (K Doses)
    Table 90. Asia Decoagulant Sales by Application (2025-2030) & (K Doses)
    Table 91. Asia Decoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 92. Asia Decoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 93. Asia Decoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 94. Asia Decoagulant Revenue by Region (2019-2024) & (US$ Million)
    Table 95. Asia Decoagulant Revenue by Region (2025-2030) & (US$ Million)
    Table 96. Asia Decoagulant Sales by Region (2019-2024) & (K Doses)
    Table 97. Asia Decoagulant Sales by Region (2025-2030) & (K Doses)
    Table 98. Middle East, Africa and Latin America Decoagulant Sales by Type (2019-2024) & (K Doses)
    Table 99. Middle East, Africa and Latin America Decoagulant Sales by Type (2025-2030) & (K Doses)
    Table 100. Middle East, Africa and Latin America Decoagulant Revenue by Type (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Decoagulant Revenue by Type (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Decoagulant Sales by Application (2019-2024) & (K Doses)
    Table 103. Middle East, Africa and Latin America Decoagulant Sales by Application (2025-2030) & (K Doses)
    Table 104. Middle East, Africa and Latin America Decoagulant Revenue by Application (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Decoagulant Revenue by Application (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Decoagulant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 107. Middle East, Africa and Latin America Decoagulant Revenue by Country (2019-2024) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Decoagulant Revenue by Country (2025-2030) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Decoagulant Sales by Country (2019-2024) & (K Doses)
    Table 110. Middle East, Africa and Latin America Decoagulant Sales by Country (2025-2030) & (K Doses)
    Table 111. Sanofi Company Information
    Table 112. Sanofi Description and Major Businesses
    Table 113. Sanofi Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 114. Sanofi Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Sanofi Recent Developments
    Table 116. Bayer Company Information
    Table 117. Bayer Description and Major Businesses
    Table 118. Bayer Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 119. Bayer Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Bayer Recent Developments
    Table 121. Boehringer Ingelheim Company Information
    Table 122. Boehringer Ingelheim Description and Major Businesses
    Table 123. Boehringer Ingelheim Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 124. Boehringer Ingelheim Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Boehringer Ingelheim Recent Developments
    Table 126. Johnson & Johnson Company Information
    Table 127. Johnson & Johnson Description and Major Businesses
    Table 128. Johnson & Johnson Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 129. Johnson & Johnson Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Johnson & Johnson Recent Developments
    Table 131. Genentech (Roche) Company Information
    Table 132. Genentech (Roche) Description and Major Businesses
    Table 133. Genentech (Roche) Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 134. Genentech (Roche) Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Genentech (Roche) Recent Developments
    Table 136. AstraZeneca Company Information
    Table 137. AstraZeneca Description and Major Businesses
    Table 138. AstraZeneca Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 139. AstraZeneca Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. AstraZeneca Recent Developments
    Table 141. Bristol-Myers Squibb Company Information
    Table 142. Bristol-Myers Squibb Description and Major Businesses
    Table 143. Bristol-Myers Squibb Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 144. Bristol-Myers Squibb Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Bristol-Myers Squibb Recent Developments
    Table 146. Aspen Company Information
    Table 147. Aspen Description and Major Businesses
    Table 148. Aspen Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 149. Aspen Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Aspen Recent Developments
    Table 151. Lilly Company Information
    Table 152. Lilly Description and Major Businesses
    Table 153. Lilly Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 154. Lilly Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Lilly Recent Developments
    Table 156. Otsuka Company Information
    Table 157. Otsuka Description and Major Businesses
    Table 158. Otsuka Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 159. Otsuka Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Otsuka Recent Developments
    Table 161. Pfizer Company Information
    Table 162. Pfizer Description and Major Businesses
    Table 163. Pfizer Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 164. Pfizer Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Pfizer Recent Developments
    Table 166. Daiichi Sankyo Company Information
    Table 167. Daiichi Sankyo Description and Major Businesses
    Table 168. Daiichi Sankyo Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 169. Daiichi Sankyo Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Daiichi Sankyo Recent Developments
    Table 171. The Medicines Company Company Information
    Table 172. The Medicines Company Description and Major Businesses
    Table 173. The Medicines Company Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 174. The Medicines Company Decoagulant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. The Medicines Company Recent Developments
    Table 176. Key Raw Materials Lists
    Table 177. Raw Materials Key Suppliers Lists
    Table 178. Decoagulant Distributors List
    Table 179. Decoagulant Customers List
    Table 180. Decoagulant Market Trends
    Table 181. Decoagulant Market Drivers
    Table 182. Decoagulant Market Challenges
    Table 183. Decoagulant Market Restraints
    Table 184. Research Programs/Design for This Report
    Table 185. Key Data Information from Secondary Sources
    Table 186. Key Data Information from Primary Sources
List of Figures
    Figure 1. Decoagulant Product Picture
    Figure 2. Global Decoagulant Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Decoagulant Market Share by Type in 2023 & 2030
    Figure 4. Platelet Aggregation Inhibitors (PAI) Product Picture
    Figure 5. Low-Molecular-Weight Heparin (LMWH) Product Picture
    Figure 6. Direct Thrombin Inhibitor (DTI) Product Picture
    Figure 7. Direct Factor Xa Inhibitors (DFXa) Product Picture
    Figure 8. Vitamin K Antagonists (VKA) Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Decoagulant Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Decoagulant Market Share by Application in 2023 & 2030
    Figure 12. VTE
    Figure 13. ACS/MI
    Figure 14. AF
    Figure 15. Others
    Figure 16. Decoagulant Report Years Considered
    Figure 17. Global Decoagulant Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Decoagulant Revenue 2019-2030 (US$ Million)
    Figure 19. Global Decoagulant Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 20. Global Decoagulant Revenue Market Share by Region (2019-2030)
    Figure 21. Global Decoagulant Sales 2019-2030 ((K Doses)
    Figure 22. Global Decoagulant Sales Market Share by Region (2019-2030)
    Figure 23. US & Canada Decoagulant Sales YoY (2019-2030) & (K Doses)
    Figure 24. US & Canada Decoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Decoagulant Sales YoY (2019-2030) & (K Doses)
    Figure 26. Europe Decoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. China Decoagulant Sales YoY (2019-2030) & (K Doses)
    Figure 28. China Decoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Asia (excluding China) Decoagulant Sales YoY (2019-2030) & (K Doses)
    Figure 30. Asia (excluding China) Decoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. Middle East, Africa and Latin America Decoagulant Sales YoY (2019-2030) & (K Doses)
    Figure 32. Middle East, Africa and Latin America Decoagulant Revenue YoY (2019-2030) & (US$ Million)
    Figure 33. The Decoagulant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 34. The Top 5 and 10 Largest Manufacturers of Decoagulant in the World: Market Share by Decoagulant Revenue in 2023
    Figure 35. Global Decoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 36. Global Decoagulant Sales Market Share by Type (2019-2030)
    Figure 37. Global Decoagulant Revenue Market Share by Type (2019-2030)
    Figure 38. Global Decoagulant Sales Market Share by Application (2019-2030)
    Figure 39. Global Decoagulant Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Decoagulant Sales Market Share by Type (2019-2030)
    Figure 41. US & Canada Decoagulant Revenue Market Share by Type (2019-2030)
    Figure 42. US & Canada Decoagulant Sales Market Share by Application (2019-2030)
    Figure 43. US & Canada Decoagulant Revenue Market Share by Application (2019-2030)
    Figure 44. US & Canada Decoagulant Revenue Share by Country (2019-2030)
    Figure 45. US & Canada Decoagulant Sales Share by Country (2019-2030)
    Figure 46. U.S. Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 47. Canada Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 48. Europe Decoagulant Sales Market Share by Type (2019-2030)
    Figure 49. Europe Decoagulant Revenue Market Share by Type (2019-2030)
    Figure 50. Europe Decoagulant Sales Market Share by Application (2019-2030)
    Figure 51. Europe Decoagulant Revenue Market Share by Application (2019-2030)
    Figure 52. Europe Decoagulant Revenue Share by Country (2019-2030)
    Figure 53. Europe Decoagulant Sales Share by Country (2019-2030)
    Figure 54. Germany Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 55. France Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 56. U.K. Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 57. Italy Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 58. Russia Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 59. China Decoagulant Sales Market Share by Type (2019-2030)
    Figure 60. China Decoagulant Revenue Market Share by Type (2019-2030)
    Figure 61. China Decoagulant Sales Market Share by Application (2019-2030)
    Figure 62. China Decoagulant Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Decoagulant Sales Market Share by Type (2019-2030)
    Figure 64. Asia Decoagulant Revenue Market Share by Type (2019-2030)
    Figure 65. Asia Decoagulant Sales Market Share by Application (2019-2030)
    Figure 66. Asia Decoagulant Revenue Market Share by Application (2019-2030)
    Figure 67. Asia Decoagulant Revenue Share by Region (2019-2030)
    Figure 68. Asia Decoagulant Sales Share by Region (2019-2030)
    Figure 69. Japan Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 70. South Korea Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 71. China Taiwan Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 72. Southeast Asia Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 73. India Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 74. Middle East, Africa and Latin America Decoagulant Sales Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Decoagulant Revenue Market Share by Type (2019-2030)
    Figure 76. Middle East, Africa and Latin America Decoagulant Sales Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Decoagulant Revenue Market Share by Application (2019-2030)
    Figure 78. Middle East, Africa and Latin America Decoagulant Revenue Share by Country (2019-2030)
    Figure 79. Middle East, Africa and Latin America Decoagulant Sales Share by Country (2019-2030)
    Figure 80. Brazil Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 81. Mexico Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 82. Turkey Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 83. Israel Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 84. GCC Countries Decoagulant Revenue (2019-2030) & (US$ Million)
    Figure 85. Decoagulant Value Chain
    Figure 86. Decoagulant Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed